Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm
- DOI
- 10.1182/blood.2026035465
- Published
- 2026-11-05
- Container
- Blood Journal
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2026035465,
title = {Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm},
author = {Olivier Hermine and Orianne Debeaupuis and Gandhi-Laurent Damaj and Johannes Lübke and Juliana Schwaab and Marc Heizmann and Frank Siebenhaar and Polina Pyatilova and Nicole Nojarov and Marek Niedoszytko and Aleksandra Górska and Mattias Mattsson and Khalid Shoumariyeh and Stephan de Bra and Friederike Wortmann and Nikolas von Bubnoff and Horia Bumbea and Delia Soare and Chiara Elena and Judit Varkonyi and Anna Belloni Fortina and Simge Erdem and Knut Brockow and Tobias Franz and Jens P. Panse and Deborah Christen and Christine Breynaert and Akif Selim Yavuz and Luca Malcovati and Michael Doubek and Vito Sabato and Ilaria Tanasi and Massimiliano Bonifacio and Karin Hartmann and Axel Rüfer and Mariarita Sciumè and Valentina Bellani and Irena Angelova-Fischer and Alex Stefan and Massimo Triggiani and Roberta Parente and Saskia K Klein and Michael Makris and Sotirios G. Papageorgiou and Paul van Daele and Ingunn Dybedal and Daniel Baffoe and Theo Gulen and Madlen Jentzsch and Olivier Lortholary and Maël Heiblig and Cristina Bulai Livideanu and Stéphane Barete and Clément Gourguechon and Sophie Dimicoli-Salazar and Olivier Tournilhac and Laurent Frenzel and Michel Arock and Andrzej Mital and Johannes N. Woltsche and Hanneke C. Kluin-Nelemans and Hanneke N.G. Oude Elberink and Jason Gotlib and Martina Sperr and Andreas Reiter and Peter Valent and Wolfgang R. Sperr and Julien Rossignol},
year = {2026},
journal = {Blood Journal},
doi = {10.1182/blood.2026035465},
url = {https://doi.org/10.1182/blood.2026035465}
}RIS
TY - JOUR TI - Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm AU - Olivier Hermine AU - Orianne Debeaupuis AU - Gandhi-Laurent Damaj AU - Johannes Lübke AU - Juliana Schwaab AU - Marc Heizmann AU - Frank Siebenhaar AU - Polina Pyatilova AU - Nicole Nojarov AU - Marek Niedoszytko AU - Aleksandra Górska AU - Mattias Mattsson AU - Khalid Shoumariyeh AU - Stephan de Bra AU - Friederike Wortmann AU - Nikolas von Bubnoff AU - Horia Bumbea AU - Delia Soare AU - Chiara Elena AU - Judit Varkonyi AU - Anna Belloni Fortina AU - Simge Erdem AU - Knut Brockow AU - Tobias Franz AU - Jens P. Panse AU - Deborah Christen AU - Christine Breynaert AU - Akif Selim Yavuz AU - Luca Malcovati AU - Michael Doubek AU - Vito Sabato AU - Ilaria Tanasi AU - Massimiliano Bonifacio AU - Karin Hartmann AU - Axel Rüfer AU - Mariarita Sciumè AU - Valentina Bellani AU - Irena Angelova-Fischer AU - Alex Stefan AU - Massimo Triggiani AU - Roberta Parente AU - Saskia K Klein AU - Michael Makris AU - Sotirios G. Papageorgiou AU - Paul van Daele AU - Ingunn Dybedal AU - Daniel Baffoe AU - Theo Gulen AU - Madlen Jentzsch AU - Olivier Lortholary AU - Maël Heiblig AU - Cristina Bulai Livideanu AU - Stéphane Barete AU - Clément Gourguechon AU - Sophie Dimicoli-Salazar AU - Olivier Tournilhac AU - Laurent Frenzel AU - Michel Arock AU - Andrzej Mital AU - Johannes N. Woltsche AU - Hanneke C. Kluin-Nelemans AU - Hanneke N.G. Oude Elberink AU - Jason Gotlib AU - Martina Sperr AU - Andreas Reiter AU - Peter Valent AU - Wolfgang R. Sperr AU - Julien Rossignol PY - 2026 JO - Blood Journal DO - 10.1182/blood.2026035465 UR - https://doi.org/10.1182/blood.2026035465 ER -
APA
Hermine, O., Debeaupuis, O., Damaj, G., Lübke, J., Schwaab, J., Heizmann, M., Siebenhaar, F., Pyatilova, P., Nojarov, N., Niedoszytko, M., Górska, A., Mattsson, M., Shoumariyeh, K., Bra, S. D., Wortmann, F., Bubnoff, N. V., Bumbea, H., Soare, D., Elena, C., Varkonyi, J., Fortina, A. B., Erdem, S., Brockow, K., Franz, T., Panse, J. P., Christen, D., Breynaert, C., Yavuz, A. S., Malcovati, L., Doubek, M., Sabato, V., Tanasi, I., Bonifacio, M., Hartmann, K., Rüfer, A., Sciumè, M., Bellani, V., Angelova-Fischer, I., Stefan, A., Triggiani, M., Parente, R., Klein, S. K., Makris, M., Papageorgiou, S. G., Daele, P. V., Dybedal, I., Baffoe, D., Gulen, T., Jentzsch, M., Lortholary, O., Heiblig, M., Livideanu, C. B., Barete, S., Gourguechon, C., Dimicoli-Salazar, S., Tournilhac, O., Frenzel, L., Arock, M., Mital, A., Woltsche, J. N., Kluin-Nelemans, H. C., Elberink, H. N. O., Gotlib, J., Sperr, M., Reiter, A., Valent, P., Sperr, W. R., & Rossignol, J. (2026). Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm. Blood Journal. https://doi.org/10.1182/blood.2026035465
Source records
- crossref · retrieved 2026-11-07T16:30:18.313Z